lobbying_activities: 3435363

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3435363	8f195b95-1257-4ed9-9e31-736160a8220c	Q3	DESIMONE CONSULTING, LLC	400931695	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)	2025	third_quarter	PHA	Issues related to patient access and pricing. Issues related to policy changes to Medicare Part D. Issues related to 340B reform. Issues related to the EPIC (Ensuring Pathways to Innovative Cures) Act, H.R.1492/S.832. Issues related to Most Favored Nation (MFN) policy. Issues related to PBM reform.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2025-10-15T22:33:47-04:00